CRESCENT BIOPHARMA, INC. (CBIO) Institutional Ownership & Insider Trading
80 institutions reported holding CRESCENT BIOPHARMA, INC. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 18 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CBIOCRESCENT BIOPHARMA, INC.Follow CBIO — free
—
Price chart with a free account
- Market cap
- 476.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters80 institutions held 78.4% of the shares. Across filers that reported both quarters, shares held changed +15.9%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 80 | 29 | +15.9% | 16 | 31 | 14 | 12 |
| Mar 26 | 60 | 25 | +5.1% | 17 | 14 | 8 | 10 |
| Dec 25 | 56 | 24 | +111.5% | 15 | 20 | 8 | 6 |
| Sep 25 | 41 | 11 | +5.3% | 6 | 15 | 8 | 4 |
| Jun 25 | 30 | 11 | — | — | — | — | — |
CRESCENT BIOPHARMA, INC. — questions
- Who owns CRESCENT BIOPHARMA, INC. stock?
- 80 institutions reported CRESCENT BIOPHARMA, INC. shares in 13F filings for the quarter ended 2026-06-30. The largest: FMR LLC (11.1%), BVF INC/IL (7.4%), Fairmount Funds Management LLC (7.4%).
- Are CRESCENT BIOPHARMA, INC. insiders buying or selling?
- 18 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from CRESCENT BIOPHARMA, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.